Evidence map›Paper›PMID 22254038›Full record

ReviewNutrients2010

Is excess calcium harmful to health?

Robin M Daly, Peter R Ebeling

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Insights from Decades of Supplementing Calcium and Vitamin D.Endocrinology and metabolism (Seoul, Korea) · 2024
    Article
  5. Unlocking New Approaches to Urolithiasis ManagementCurrent pharmaceutical biotechnology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The calcium scare--what would Austin Bradford Hill have thought?Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2011
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Robin M DalyDepartment of Medicine, The University of Melbourne, Western Hospital, Melbourne 3011, Australia. rdaly@unimelb.edu.au
Peter R Ebeling
Western Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most current guidelines recommend that older adults and the elderly strive for a total calcium intake (diet and supplements) of 1,000 to 1,300 mg/day to prevent osteoporosis and fractures. Traditionally, calcium supplements have been considered safe, effective and well tolerated, but their safety has recently been questioned due to potential adverse effects on vascular disease which may increase mortality. For example, the findings from a meta-analysis of randomized controlled trials (currently published in abstract form only) revealed that the use of calcium supplements was associated with an ~30% increased risk of myocardial infarction. If high levels of calcium are harmful to health, this may alter current public health recommendations with regard to the use of calcium supplements for preventing osteoporosis. In this review, we provide an overview of the latest information from human observational and prospective studies, randomized controlled trials and meta-analyses related to the effects of calcium supplementation on vascular disease and related risk factors, including blood pressure, lipid and lipoprotein levels and vascular calcification.

Indexed as

AdultAgedAged, 80 and overBlood PressureCalcium, DietaryCardiovascular DiseasesCerebrovascular DisordersDietary SupplementsFemaleHumansKidney CalculiLipidsMaleMeta-Analysis as TopicMiddle AgedOsteoporosisCalcium, DietaryLipidscalcium supplementationcardiovascular diseaseelderlymortality

Identifiers

PMID22254038
PMCPMC3257663
OpenAlexW2137614186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.